Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Montejano et al., Clinical Infectious Diseases, doi:10.1093/cid/ciac628
https://c19early.org/montejano.html